Roth Capital Maintains Buy on Electromed, Raises Price Target to $35
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Roth Capital analyst Kyle Bauser maintains Electromed (AMEX:ELMD) with a Buy and raises the price target from $29 to $35.
Roth Capital analyst Kyle Bauser maintains Electromed (AMEX:ELMD) with a Buy and raises the price target from $29 to $35.